Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia

NCT00001575

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +8 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Mozobil for Autologous Stem Cell Mobilization

NCT01164345

Conditions: Autologous Stem Cell Transplantation, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: Chaim Sheba Medical Center Tel Litwinsky, Israel

View Trial Details

Completed

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

NCT01321346

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +20 more
Locations: Childrens Hospital Los Angeles Los Angeles, California, United States

UCSF School of Medicine San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

University of Miami Cancer Center Miami, Florida, United States

View all 20 locations

View Trial Details

Completed

Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies

NCT01421173

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma

NCT00561756

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

B-Receptor Signaling in Cardiomyopathy

NCT01135849

Conditions: Adenocarcinoma, Adenoma, Amyloidosis, +140 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab

NCT00240591

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Completed

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

NCT00079391

Conditions: Bone Marrow Diseases, Bone Marrow Transplant Rejection, Chronic Disease, +28 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00005592

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations: University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States

Lombardi Cancer Center Washington D.C., District of Columbia, United States

View Trial Details

Completed

A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

NCT01007292

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Site US2778 John B. Amos Cancer Center Columbus, Georgia, United States

Site US55 Loyola University Hospital - Maywood Maywood, Illinois, United States

Site US9 Mount Sinai School of Medicine New York, United States

Site US2802 Mecklenburg Medical Group Charlotte, North Carolina, United States

View all 19 locations

View Trial Details